Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001763494-26-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 18, 2026 |
| Document | View SEC Filing |
Transactions
14
Total Shares
1,200,000
Total Value
$34,726,729.21
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Sep 15, 2026 | Exercise/Conversion | 95,666 | $23.34 | $2,232,844.44 | 528,552 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 15, 2026 | Sale | 63,498 | $61.99 | $3,936,526.76 | 465,054 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 15, 2026 | Sale | 28,796 | $62.66 | $1,804,222.02 | 436,258 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 15, 2026 | Sale | 3,102 | $63.64 | $197,421.83 | 433,156 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 15, 2026 | Sale | 270 | $65.31 | $17,633.70 | 432,886 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 16, 2026 | Exercise/Conversion | 195,841 | $23.34 | $4,570,928.94 | 628,727 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 16, 2026 | Sale | 99,716 | $63.26 | $6,307,964.36 | 529,011 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 16, 2026 | Sale | 96,125 | $63.64 | $6,117,289.26 | 432,886 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 17, 2026 | Exercise/Conversion | 108,493 | $23.34 | $2,532,226.62 | 541,379 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 17, 2026 | Sale | 101,691 | $64.59 | $6,567,875.94 | 439,688 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 17, 2026 | Sale | 6,802 | $64.95 | $441,795.34 | 432,886 | Direct | โ | View Details | |
Director | Employee stock option (right to buy) | Derivative | Sep 15, 2026 | Exercise/Conversion | 95,666 | $0.00 | $0.00 | 304,334 | Direct | โ | View Details | |
Director | Employee stock option (right to buy) | Derivative | Sep 16, 2026 | Exercise/Conversion | 195,841 | $0.00 | $0.00 | 108,493 | Direct | โ | View Details | |
Director | Employee stock option (right to buy) | Derivative | Sep 17, 2026 | Exercise/Conversion | 108,493 | $0.00 | $0.00 | 0 | Direct | โ | View Details |